LICOLLARI A[au] - Search Results

Year	Number of Results
2016	1
2017	3
2018	3
2019	2
2021	1
2023	0

1

Safety Evaluation for Restorin® NMN, a NAD+ Precursor.

Turner J, Licollari A, Mihalcea E, Tan A. Turner J, et al. Among authors: licollari a. Front Pharmacol. 2021 Nov 11;12:749727. doi: 10.3389/fphar.2021.749727. eCollection 2021. Front Pharmacol. 2021. PMID: 34867355 Free PMC article.

2

Improving the selectivity and sensitivity for quantifying 8-α-hydroxy-mutilin in rabbit tissues by using basic mobile phases and negative ionization.

Tan A, Gu G, Gui X, Wu Y, Bolger G, Licollari A, Fanaras JC. Tan A, et al. Among authors: licollari a. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:142-148. doi: 10.1016/j.jchromb.2017.11.008. Epub 2017 Nov 11. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 29153999

3

Use of basic mobile phase to improve chromatography and boost sensitivity for quantifying tetrahydrocurcumin in human plasma by LC-MS/MS.

Tan A, Wu Y, Wong M, Licollari A, Bolger G, Fanaras JC, Shopp G, Helson L. Tan A, et al. Among authors: licollari a. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:86-93. doi: 10.1016/j.jchromb.2016.06.010. Epub 2016 Jun 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 27327398

4

Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia.

Bolger GT, Licollari A, Tan A, Greil R, Pleyer L, Vcelar B, Majeed M, Sordillo P. Bolger GT, et al. Among authors: licollari a. Anticancer Res. 2018 Jan;38(1):121-130. doi: 10.21873/anticanres.12199. Anticancer Res. 2018. PMID: 29277764

5

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.

Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Majeed M, Sordillo PP. Bolger GT, et al. Among authors: licollari a. Cancer Chemother Pharmacol. 2019 Feb;83(2):265-275. doi: 10.1007/s00280-018-3730-5. Epub 2018 Nov 14. Cancer Chemother Pharmacol. 2019. PMID: 30430227

6

Safety and Biosimilarity of ior^®LeukoCIM Compared to Neupogen^® Based on Toxicity, Pharmacodynamic, and Pharmacokinetic Studies in the Sprague-Dawley Rat.

Licollari A, Riddle K, Taylor SR, Ledon N, Bolger GT. Licollari A, et al. J Pharm Sci. 2017 Jun;106(6):1475-1481. doi: 10.1016/j.xphs.2017.02.009. Epub 2017 Feb 24. J Pharm Sci. 2017. PMID: 28238900

7

Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells.

Bolger GT, Licollari A, Bagshaw R, Tan A, Greil R, Vcelar B, Majeed M, Sordillo P. Bolger GT, et al. Among authors: licollari a. Anticancer Res. 2019 Mar;39(3):1161-1168. doi: 10.21873/anticanres.13225. Anticancer Res. 2019. PMID: 30842145

8

Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance.

Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Majeed M, Helson L. Bolger GT, et al. Among authors: licollari a. Anticancer Res. 2017 Jul;37(7):3483-3492. doi: 10.21873/anticanres.11716. Anticancer Res. 2017. PMID: 28668837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results